Journal of Thoracic Oncology

Published by: Elsevier Inc.  

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Drilon
    Drilon
  4. Rudin
    Rudin
  5. Ladanyi
    Ladanyi
  6. Yu
    Yu
  7. Paik
    Paik
  8. Rusch
    Rusch
  9. Rekhtman
    Rekhtman
  10. Travis
    Travis

Groups

  1. Department of Medicine (513)
  2. Solid Tumor Oncology Division (513)
  3. Thoracic Oncology (513)
  4. GSK Faculty (137)
  5. Department of Pathology and Laboratory Medicine (118)
  6. Surgery (89)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (84)
  8. Weinberg Fellows (77)
  9. Human Oncology and Pathogenesis Program (76)
  10. Tow Center for Developmental Oncology (TCDO) (67)
Search Within
  1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (378)
  2. Journal Article (125)
  3. Review (4)
  4. Correspondence (3)
  5. Editorial (3)
Groups
  1. Department of Medicine (513)
  2. Solid Tumor Oncology Division (513)
  3. Thoracic Oncology (513)
  4. GSK Faculty (137)
  5. Department of Pathology and Laboratory Medicine (118)
  6. Surgery (89)

More Groups

People
  1. Mark Kris (131)
  2. Gregory Riely (112)
  3. Alexander Drilon (84)
  4. Charles Rudin (79)
  5. Marc Ladanyi (65)
  6. Helena Yu (62)

More People

Years
  1. 2025 (12)
  2. 2024 (37)
  3. 2023 (56)
  4. 2022 (31)
  5. 2021 (73)
  6. 2020 (15)

More Years

Publishers
  1. Elsevier Inc. (513)

Results (513)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Osimertinib (osi) + datopotamab deruxtecan (Dato-DXd) in patients (pts) with EGFR-mutated (EGFRm) advanced NSCLC (aNSCLC) whose disease progressed on first-line (1L) osi: ORCHARD
    Meeting Abstract

    Le, X.; Hendriks, L.; Morabito, A.; Bonanno, L.; Okamoto, I.; Goldman, J. W.; Yu, H. A.; Brustugun, O. T.; Halvorsen, T. O.; Kim, Y. J.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Tepotinib in patients (pts) with METexon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes
    Meeting Abstract

    Mazieres, J.; Veillon, R.; Cortot, A.; Ferrara, R.; Felip, E.; Garassino, M.; Le, X.; Thomas, M.; Sakai, H.; Smit, E.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Dual Targeting of RET and SRC to Treat RET-Positive Non-Small Cell Lung Cancer
    Meeting Abstract

    Son, J.; Rix, L. L. R.; Fang, B.; Welsh, E. A.; Drilon, A.; Koomen, J. M.; Cocco, E.; Rix, U.
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Punekar, S. R.; Hong, D. S.; Luo, J.; Ou, S. H. I.; Johnson, M. L.; Spira, A.; Garrido-Laguna, I.; Goldman, J. W.; Herzberg, B.; Saltos, A.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Chemo-immunotherapy for borderline resectable and unresectable NSCLC
    Meeting Abstract

    Cappuzzo, F.; Landi, L.; Garbo, E.; Cooper, A.; Wang, X.; Mayoral, M.; Ginsberg, M. S.; Sholl, L.; Nishino, M.; Bott, M.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • A randomized phase III study of ivonescimab versus pembrolizumab as first-line treatment of metastatic non-small cell lung cancer as first-line treatment of metastatic non-small cell lung cancer with high tumor PD-L1 expression: HARMONi-7
    Meeting Abstract

    Passaro, A.; Girard, N.; Rodriguez Abreu, D.; Gumus, M.; Wu, Y. L.; Syrigos, K.; Ramlau, R.; Santos, E.; Berz, D.; Gandhi, C.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Phase I study of patritumab deruxtecan (HER3-DXd) in patients (pts) with advanced KRAS G12C non-small cell lung cancer (NSCLC): Study U102 cohort 5
    Meeting Abstract

    Paz-Ares, L.; Steuer, C.; Ruiter, G.; Nishio, M.; Murakami, H.; Kim, D. W.; Felip, E.; Baik, C. S.; Lin, C. C.; Massarelli, E.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • TROPION-Lung15: A phase III study of datopotamab deruxtecan (Dato-DXd) ± osimertinib vs platinum doublet chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) and disease progression on prior osimertinib
    Meeting Abstract

    Nadal, E.; Cheema, P. K.; Wu, Y. L.; Ahn, M. J.; Tanizaki, J.; Gharagoozloo, S.; Nizialek, E.; Shi, X.; van der Gronde, T.; Yu, H. A.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Enhancing enrollment to 1L NSCLC trials by allowing 1 prior cycle of standard of care (SOC): SUNRAY-01 experience
    Meeting Abstract

    Hochmair, M. J.; Arbour, K. C.; Negrao, M. V.; Cappuzzo, F.; Dingemans, A. M. C.; Girard, N.; Gronberg, B. H.; Leal, T. A.; Lindsay, C.; Lu, S.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Tepotinib in patients (pts) with METexon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes
    Meeting Abstract

    Mazieres, J.; Veillon, R.; Cortot, A.; Ferrara, R.; Felip, E.; Garassino, M.; Le, X.; Thomas, M.; Sakai, H.; Smit, E.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save

    • Journal of Thoracic Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Science, Inc.
    Journal of Thoracic Oncology 15560864 2024
    Journal of Thoracic Oncology 1556-1380 Elsevier Inc.
    Journal of Thoracic Oncology 15561380 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Science, Inc.
    Journal of Thoracic Oncology 1556-1380 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Lippincott Williams & Wilkins
    Journal of Thoracic Oncology 1556-1380 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 2019
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15560864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15561380 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 0959-8049 Unknown
    Journal of Thoracic Oncology 15560864 2022
    Journal of Thoracic Oncology 15560864 2021
    Journal of Thoracic Oncology 15560864 2023
    Journal of Thoracic Oncology 1556-0864 Elsevier Science, Inc.
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15561380 Unknown
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 Unknown
    Journal of Thoracic Oncology 15560864 2012
    Journal of Thoracic Oncology 1556-1380 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 15560864 International Association
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 College of American Pathologists, American Society for Investigative Pathology, Association for Molecular Pathology, and the International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 15560864 International Association for the Study of Lung Cancer
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Elsevier Inc.
    Journal of Thoracic Oncology 1556-0864 Unknown
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 15561380 Unknown
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 1556-1380 Ovid Technologies, Inc.
    Unknown (1556-0864) 1556-0864 Unknown